Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Bolla, K. I. Articles by London, E. D. Search for Related Content PubMed Citation Articles by Bolla, K. I. Articles by London, E. D. Cocaine

The Neuropsychiatry of Chronic Cocaine Abuse

Received April 22, 1997; revised June 24, 1997; accepted July 1, 1997. From the Department of Neurology, Johns Hopkins University School of Medicine, Hopkins Bayview Research Campus; and Molecular Neuropsychiatry Section and Brain Imaging Center, National Institute on Drug Abuse, Baltimore, Maryland. Address correspondence to Dr. Bolla, Johns Hopkins Bayview Medical Center, Department of Neurology, 4940 Eastern Ave., Baltimore, MD 21224.

This review integrates findings from neuropsychological, PET, and MRI studies in human subjects and neurochemical findings in animals to make inferences about neuropsychiatric consequences of chronic abuse of cocaine. It also aims to develop insights into brain–behavioral relationships that may explain the perpetuation of addictive behaviors. Such insights promise to lead to a better understanding of the neuropsychiatry of cocaine abuse and to promote the development of more efficacious treatments. The authors present evidence suggesting that cocaine abusers have specific dysfunction of executive functions (decision making, judgment) and that this behavior is associated with dysfunction of specific prefrontal brain regions, the orbitofrontal cortex, and anterior cingulate gyrus. Suggestions for future research and treatment are also discussed.

Key Words: Substance Abuse • Cocaine • Executive Functions

This article has been cited by other articles:

				T. J.R Beveridge, K. E Gill, C. A Hanlon, and L. J Porrino Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys Phil Trans R Soc B, October 12, 2008; 363(1507): 3257 - 3266. [Abstract] [Full Text] [PDF]

				S. Liu, R. P. Heitz, A. R. Sampson, W. Zhang, and C. W. Bradberry Evidence of Temporal Cortical Dysfunction in Rhesus Monkeys following Chronic Cocaine Self-Administration Cereb Cortex, September 1, 2008; 18(9): 2109 - 2116. [Abstract] [Full Text] [PDF]

				F. Fumagalli, F. Bedogni, A. Frasca, L. Di Pasquale, G. Racagni, and M. A. Riva Corticostriatal Up-Regulation of Activity-Regulated Cytoskeletal-Associated Protein Expression after Repeated Exposure to Cocaine Mol. Pharmacol., November 1, 2006; 70(5): 1726 - 1734. [Abstract] [Full Text] [PDF]

				J. C. Cole, H. R. Sumnall, G. W. Smith, and A. Rostami-Hodjegan Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs J Psychopharmacol, January 1, 2005; 19(1): 67 - 70. [Abstract] [PDF]

				B. Kolb, G. Gorny, Y. Li, A.-N. Samaha, and T. E. Robinson Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens PNAS, September 2, 2003; 100(18): 10523 - 10528. [Abstract] [Full Text] [PDF]

				M. Ernst, S. J. Grant, E. D. London, C. S. Contoreggi, A. S. Kimes, and L. Spurgeon Decision Making in Adolescents With Behavior Disorders and Adults With Substance Abuse Am J Psychiatry, January 1, 2003; 160(1): 33 - 40. [Abstract] [Full Text] [PDF]

				B. M. Lester, E. Z. Tronick, L. LaGasse, R. Seifer, C. R. Bauer, S. Shankaran, H. S. Bada, L. L. Wright, V. L. Smeriglio, J. Lu, et al. The Maternal Lifestyle Study: Effects of Substance Exposure During Pregnancy on Neurodevelopmental Outcome in 1-Month-Old Infants Pediatrics, December 1, 2002; 110(6): 1182 - 1192. [Abstract] [Full Text] [PDF]

				K.I. Bolla, K. Brown, D. Eldreth, K. Tate, and J.L. Cadet Dose-related neurocognitive effects of marijuana use Neurology, November 12, 2002; 59(9): 1337 - 1343. [Abstract] [Full Text] [PDF]

				J. C. Cole, H. R. Sumnall, and G. F. Wagstaff What is a dose of ecstasy? J Psychopharmacol, March 1, 2002; 16(2): 189 - 190. [PDF]

				M. R. Basso and R. A. Bornstein Neurobehavioural consequences of substance abuse and HIV infection J Psychopharmacol, May 1, 2000; 14(3): 228 - 237. [Abstract] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1998 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us